Other
Antiplatelet Drug
0
Pipeline Programs↗
1
Active Trials↗
0
Companies Involved↗
Antiplatelet Drug is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
6
clinical trials
Withdrawn2 · 33%
Completed1 · 17%
Recruiting1 · 17%
Unknown status1 · 17%
Terminated1 · 17%
Clinical Trials
Trial Activity
6 trials
Clinical Management of Antiplatelet Drug Resistance in Patients With Drug Eluting Coronary Stents
Withdrawn·—·Phase 4·NCT00589862
Pharmacokinetics of Antiplatelet Drugs in Diabetic pAtients
Withdrawn·—·Phase 4·NCT02302508
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)